Copyright © 2004 American Chemical Society
 

May 24, 2004 Issue

Volume 82, Issue 21
8221cov1a
May 24, 2004 Issue, Vol. 82 | Iss. 21
A small battery of drugs has been approved to treat respiratory viral infections; more are on the way
By LOUISA WRAY DALTON
(pp. 45-53)
Features
Government & Policy
NIH's newest institute director sees bright future for chemistry at NIGMS and NIH (pp. 25-30)
Science & Technology
Alfred University trains some of the world's top glass and ceramics engineers and artists (pp. 33-39)
Back Issues
 

News of the Week

IRAQ SHELL MAY CONTAIN SARIN

Experts question type of shell, whether it was part of a stockpile
(p.9)

DETOX LETS CROPS TAKE HERBICIDE

Thanks to an evolved enzyme, engineered crops tolerate glyphosate
(p.10)

UCB SET TO BUY U.K. BIOTECH FIRM

Belgian firm's exit from chemicals seen with Celltech deal
(p.11)

ZERHOUNI ON STEM CELLS

NIH director defends Bush policy on stem cell research to Congress
(p.11)

PROFITS SURGE FOR JAPANESE

Chemical producers benefit from strengthening of the world economy
(p.12)

MASS SPEC REPORT FOR ENZYME ASSAY

Self-assembled monolayers enable rapid screening of libraries against drug targets
(p.13)
 

Departments

Science & Technology

New Software And Websites For The Chemical Enterprise
(pp. 42-43)
Alfred University trains some of the world's top glass and ceramics engineers and artists
(pp. 33-39)
Researchers are gaining insights into how some anti-HIV drugs avoid resistance mechanisms
(pp. 40-41)
A small battery of drugs has been approved to treat respiratory viral infections; more are on the way
(pp. 45-53)

Editor's Page

Letters